Sanfilippo,GC Pharma,Regulatory,Treatment,Regulatory

Breakthrough in Genetic Disorder Treatment: GC Pharma’s Sanfilippo Syndrome Drug Receives FDA Phase 1 Approval

[su_heading size=”27″ align=”left” margin=”40″]Introduction to Sanfilippo Syndrome and GC Pharma’s Efforts[/su_heading] Sanfilippo Syndrome, also known as Mucopolysaccharidosis Type III, is…

South Korea Advances Regulation on Illegal Content Distribution by CDN Providers

[su_heading size=”27″ align=”left” margin=”40″]Introduction to New Regulatory Measures[/su_heading] The South Korean Broadcasting and Telecommunications Commission (KCC) is pushing forward with…